[Use of low molecular weight heparins].
Llau
J V
JV
Hoyas
L
L
Ezpeleta
J
J
García-Polit
J
J
D000767:Anesthesia, Epidural / Q000009:adverse effects*; D000773:Anesthesia, Obstetrical / Q000009:adverse effects*; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D020152:Antithrombin III Deficiency; D002585:Cesarean Section; D000075202:Contraindications; D017558:Elective Surgical Procedures; D005260:Female; D006801:Humans; D017762:Nadroparin / Q000008:administration & dosage* / Q000009:adverse effects; D010314:Partial Thromboplastin Time; D011183:Postoperative Complications / Q000517:prevention & control*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D013345:Subarachnoid Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D017762:Nadroparin
Consideraciones al respecto del empleo de las heparinas de bajo peso molecular.